Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |